We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of Anesthetic Method on Cerebral Oxygen Saturation in Geriatric Patients Undergoing Transurethral Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01147146
Recruitment Status : Completed
First Posted : June 22, 2010
Last Update Posted : May 13, 2011
Sponsor:
Information provided by:

Study Description
Brief Summary:
The effects of anesthetic method on cerebral oxygen saturation in geriatric patients undergoing transurethral surgery.

Condition or disease Intervention/treatment
Surgery Drug: propofol, fentanyl, atracurium Drug: bupivacaine Drug: bupivacaine, Midazolam

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 64 participants
Allocation: Randomized
Primary Purpose: Prevention
Official Title: The Effects of Anesthetic Method on Cerebral Oxygen Saturation in Geriatric Patients Undergoing Transurethral Surgery
Study Start Date : June 2010
Primary Completion Date : December 2010
Study Completion Date : December 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Intervention Details:
    Drug: propofol, fentanyl, atracurium
    general anesthesia
    Other Name: propofol 2mg/kg, fentanyl 50mg, atracurium 0.5mg/kg
    Drug: bupivacaine
    spinal anesthesia
    Other Name: bupivacaine 8-10mg
    Drug: bupivacaine, Midazolam
    spinal anesthesia & sedation
    Other Name: Bupivacine 8-10mg, Midazolam 0.5mg/kg

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   65 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • male patients (ASA physical status I and II) aged over 65 yrs and scheduled elective transurethral surgery

Exclusion Criteria:

  • cardiovascular, renal, liver disease, or cerebrovascular disorder
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01147146


Locations
Korea, Republic of
Severance Hospital, Yonsei University College of Medicine
Seoul, Korea, Republic of
Sponsors and Collaborators
Yonsei University
Investigators
Principal Investigator: Jeong-Yeon Hong, MD Anesthesiology & Pain Medicine, Severance Hospital
More Information

Responsible Party: Jeong-Yeon Hong / Associate Clinical Professor, Yonsei University, College of Medicine
ClinicalTrials.gov Identifier: NCT01147146     History of Changes
Other Study ID Numbers: 4-2010-0133
First Posted: June 22, 2010    Key Record Dates
Last Update Posted: May 13, 2011
Last Verified: May 2011

Keywords provided by Yonsei University:
transurethral surgery

Additional relevant MeSH terms:
Bupivacaine
Propofol
Anesthetics
Fentanyl
Midazolam
Atracurium
Anesthetics, Local
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Hypnotics and Sedatives
Anesthetics, Intravenous
Anesthetics, General
Analgesics, Opioid
Narcotics
Analgesics
Adjuvants, Anesthesia
Anti-Anxiety Agents
Tranquilizing Agents
Psychotropic Drugs
GABA Modulators
GABA Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Neuromuscular Nondepolarizing Agents
Neuromuscular Blocking Agents
Neuromuscular Agents
Nicotinic Antagonists
Cholinergic Antagonists